Abaco Capital (OXP)
OXP Share PerformanceMore
|52 week high||0.0000|
|52 week low||0.0000|
|52 week change||0.0000 (0.00%)|
|4 week volume||0 28/01/18|
Media for (OXP)
Latest News« previous» nextMore
21/12/2017 - 13:27 StockMarketWire
Oxford Pharmascience Group confirmed that it has completed the Demerger, under which certain operating and other as...
21/12/2017 - 10:00 RNS
RNS Number: 0617A Oxford Pharmascience Group PLC 21 December 2017 Oxford Pharmascience Group plc ("Oxford Pharmascience" or the "Company" and, together with its subsidiaries, the " Group") Completion of Demerger, Board Changes & Change of Company Name to Abaco Capital plc Unless otherwise indicated, capitalised terms in this announcement ha...
19/12/2017 - 15:50 RNS
RNS Number: 8390Z Oxford Pharmascience Group PLC 19 December 2017 Oxford Pharmascience Group plc ("Oxford Pharmascience" or the "Company") Confirmation of Capital Reductions Unless otherwise indicated, capitalised terms in this announcement have the meaning given to them in the definitions appearing in the circular issued by the Company on 10 N...
04/12/2017 - 14:22 StockMarketWire
Oxford Pharmascience Group said it has now completed the subdivision of its capital whereby each Existing Share of 0.00...
04/12/2017 - 14:14 RNS
RNS Number: 3192Y Oxford Pharmascience Group PLC 04 December 2017 Oxford Pharmascience Group plc ("Oxford Pharmascience" or the "Company") Subdivision of Capital Oxford Pharmascience Group plc (AIM: OXP) announces that, as contemplated in the Circular to Shareholders issued by the Company on 10 November 2017 and pursuant to the resolution...
29/11/2017 - 09:12 StockMarketWire
Oxford Pharmascience has received scientific advice from the Federal Drug Administration regarding the development pr...
29/11/2017 - 07:00 RNS
RNS Number: 7843X Oxford Pharmascience Group PLC 29 November 2017 Oxford Pharmascience Group plc ("Oxford Pharmascience" or the "Company") FDA Pre-IND Advice on OXPzero Ibuprofen OTC Opportunity Oxford Pharmascience, the specialty pharmaceutical company that redevelops medicines to make them better, safer and easier to take, today ann...
27/11/2017 - 14:07 StockMarketWire
Oxford Pharmascience Group has confirmed that all resolutions were passed by shareholders at today's General Meeting. T...
Latest discussion posts More
“That seems logical, I will hold on in the HOPE it passes 2p and take a small profit, if not, leave for 2 or 3 years and most probably have this same conversation again.”▼
“I've bailed after a big hit! The way I read it, they have no product. If they want to release it as planned then they need more trials which could cost millions and also, ...”▼
“I have committed today at 1.7p, my first investment ever in anything outside the FT250. From my understanding of this sector, I don't expect much movement either up or down for ...”▼
Codes & Symbols
|Symbols||OXP, LSE:OXP, OXP.L, OXP:LN, LON:OXP, XLON:OXP|
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment